[1] HO P L, LAY E J,JIAN W,et al.STAT3 activation in urothelial stem cells lead to direct progression to invasive bladder cancer[J].Cancer Res,2012,72(13):3135-3142.
[2] SUN Y,CHENG M K,GRIFFITHS T R,et al.Inhibition of STAT signalling in bladder cancer by diindolylmethane-relevance to cell adhesion,migration and proliferation[J].Curr Cancer Drug Targets,2013,13(1):57-68.
[3] 严尔福,徐莲,刘文娟,等.新型抗癌药物分子靶标STAT3的研究进展[J].现代生物医学发展,2014,14(7):1388-1391.
[4] BEDNAREK L,SYPNIEWSKI D,GAWLIK N,et al.The efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis[J].Contemp Oncol(Pozn),2012,16(4):316-321.
[5] 杨立新,张海峰,白淑芬.P53、Ki-67基因表达与膀胱癌相关性的回顾性研究[J].现代医学,2010,38(1):32-35.
[6] SUN J,YU M,LU Y,et al.Carciongenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation[J].Cancer Lett,2014,346(2):257-263.
[7] 李建,周怀君.P13K/Akt信号通路在肿瘤研究中的进展[J].东南大学学报:医学版,2014,33(3):392-395.
[8] AZIZ M H,HAFEEZ B B,SAND J M,et al.Protein kinase C mediates Stat3Ser727 phosphoorylation,Stat3-regulated gene expression and cell invasion in various human cancer cell lines via integration with MAPK[J].Oncogene,2010,29(21):3100-3109.
[9] WANG L,YI T,KORTYLEWSKI M,et al.IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J].J Exp Med,2009,206(7):1457-1464.
[10] ZHOU H,HUANG H Y,SHAPIRO E,et al.Urothelial tumor initiation requires deregulation of multiple signaling pathways:implications in target-based therapies[J].Carcinogenesis,2012,33(4):770-780.
[11] LI Z,LI X,WU S,et al.Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway[J].Cancer Sci,2014,105(8):951-955.
[12] SHEN H B,GU Z Q,JIAN K,et al.CXCR4-mediated STAT3 activation is essential for CXCL12-induced cell invasion in bladder cancer[J].Tumour Biol,2013,34(3):1839-1845.
[13] YING H,DA L,YU-XIU S,et al.TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells[J].Inflammation,2013,36(5):1064-1074.
[14] ZHANG B,LU Z,HOU Y,et al.The effects of STAT3 and survivin silencing on the growth of human bladder carcinoma cells[J].Tumour Biol,2014,35(6):5401-5407.
[15] SEN M,JOYCE S,PANAHANDEH M,et al.Targeting STAT3 abrogates EGFR inhibitor resistance in cancer[J].Clin Cancer Res,2012,18(18):4986-4996.
[16] CHEN R J,HO Y S,GUO H R,et al.Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells[J].Toxicol Sci,2008,104(2):283-293.
[17] CHEN R J,HO Y S,GUO H R,et al.Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and Beta-adrenoceptors in human bladder cancer cells[J].Toxicoi Sci,2010,115(1):118-130.
[18] 袁小鹏,曾楚楚,邢丽华,等.STAT3抑制剂WP1066对乏氧人脑胶质瘤细胞U251放射敏感性的影响[J].辐射研究与辐射工艺学报,2014,32(1):1-6.
[19] HUANG W W,YANG J S,LIN M W,et al.Cucurbitacin E induces G2/M phase arrest through STAT3/p53/p21 signaling provokes apoptosis via Fas/CD95 and mitochondria-dependent pathways in human bladder cancer T24 cells[J].Evid Based Complement Alternat Med,2012,2012:952762.
[20] WANG J,CHEN S,XU S,et al.In vivo induction of apoptosis by fucoxanthin,a marine carotenoid,associated with down-regulating STAT3/EGFR signaling in sarcoma 180(S180)xenografts-bearing mice[J].Mar Drugs,2012,10(9):2055-2068.
[21] 张大永,吴家强,吴晓明.STAT3抑制剂及其抗肿瘤活性研究进展[J].药学进展,36(7):289-299.
[22] 潘丽,张宁,牛国君,等.以STAT3为靶标的抗肿瘤药物高通量筛选模型的建立和应用[J].生物技术通报,2014,12(4):187-192. |